Inventor · disambiguated record
Chang-Chun Ling
Also filed as: LING CHANG-CHUN
15 granted patents·6 pending applications·0 citations·filing 2014–2024
84Inventor score
Top patents by PatentIndex Score
21 records- 0183US12128058B2Multi-substituent psilocybin derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2023·Granted Oct 29, 2024·0 cites·28 claims
- 0282US12133856B2Multi-substituent psilocybin derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2023·Granted Nov 5, 2024·0 cites·28 claims
- 0381US12378195B2Aminated psilocybin derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2023·Granted Aug 5, 2025·0 cites·26 claims
- 0481US2025025483A1Multi-substituent psilocybin derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2024·Application pending·0 cites
- 0579US11918594B2Multi-substituent psilocybin derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2022·Granted Mar 5, 2024·0 cites·30 claims
- 0678US2025100967A1Hydroxylated psilocybin derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2024·Application pending·0 cites
- 0774US12187679B2Hydroxylated psilocybin derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2022·Granted Jan 7, 2025·0 cites·26 claims
- 0874US11858895B2Aminated psilocybin derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2022·Granted Jan 2, 2024·0 cites·28 claims
- 0968US11891360B2Glycosylated psilocybin derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2022·Granted Feb 6, 2024·0 cites·26 claims
- 1068US11752130B2Carboxylated psilocybin derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2022·Granted Sep 12, 2023·0 cites·17 claims
- 1164US11845727B2Aldehyde and ketone derivatives of psilocybin and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2022·Granted Dec 19, 2023·0 cites·18 claims
- 1262US11931338B2Nitrilated psilocybin derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2022·Granted Mar 19, 2024·0 cites·23 claims
- 1362US9950080B2Amphiphilic cyclodextrin-based glycodendrimersUTI LP·Filed 2014·Granted Apr 24, 2018·0 cites·13 claims
- 1461US12428408B2Fused heterocyclic mescaline derivativesENVERIC BIOSCIENCES CANADA INC·Filed 2023·Granted Sep 30, 2025·0 cites·19 claims
- 1559US2023040398A1Nitrated psilocybin derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2022·Application pending·0 cites
- 1649US2018318445A1Amphiphilic cyclodextrin-based glycodendrimersUTI LP·Filed 2018·Application pending·0 cites
- 1747US11717580B2Cyclodextrin-linked polyvalent ligands for complexation of metal ionsUTI LP·Filed 2019·Granted Aug 8, 2023·0 cites·20 claims
- 1847US10662260B2Cyclodextrin-based polyanionic and non-ionic dendrimersUTI LP·Filed 2015·Granted May 26, 2020·0 cites·6 claims
- 1946US11365212B2Fluorinated N-acetyl glucosamine analogs and xylose derivativesUTI LP·Filed 2019·Granted Jun 21, 2022·0 cites·2 claims
- 2037US2018280537A1Multifunctional polyanionic cyclodextrin dendrimersUTI LP·Filed 2016·Application pending·0 cites
- 2127US2018296679A1Pharmaceutical compositions of polyanionic and non-ionic cyclodextrin-based dendrimers and uses thereofLING CHANG CHUN·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Chang-Chun Ling files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →